List of Tables
Table 1. Global Alzherimer’s Agitation/Aggression Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Antipsychotics
Table 3. Key Players of Cholinesterase Inhibitors
Table 4. Key Players of Antidepressants
Table 5. Key Players of Others
Table 6. Global Alzherimer’s Agitation/Aggression Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Alzherimer’s Agitation/Aggression Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Alzherimer’s Agitation/Aggression Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Alzherimer’s Agitation/Aggression Treatment Market Share by Region (2020-2025)
Table 10. Global Alzherimer’s Agitation/Aggression Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Alzherimer’s Agitation/Aggression Treatment Market Share by Region (2026-2031)
Table 12. Alzherimer’s Agitation/Aggression Treatment Market Trends
Table 13. Alzherimer’s Agitation/Aggression Treatment Market Drivers
Table 14. Alzherimer’s Agitation/Aggression Treatment Market Challenges
Table 15. Alzherimer’s Agitation/Aggression Treatment Market Restraints
Table 16. Global Alzherimer’s Agitation/Aggression Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Alzherimer’s Agitation/Aggression Treatment Market Share by Players (2020-2025)
Table 18. Global Top Alzherimer’s Agitation/Aggression Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzherimer’s Agitation/Aggression Treatment as of 2024)
Table 19. Ranking of Global Top Alzherimer’s Agitation/Aggression Treatment Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Alzherimer’s Agitation/Aggression Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Alzherimer’s Agitation/Aggression Treatment, Headquarters and Area Served
Table 22. Global Key Players of Alzherimer’s Agitation/Aggression Treatment, Product and Application
Table 23. Global Key Players of Alzherimer’s Agitation/Aggression Treatment, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Alzherimer’s Agitation/Aggression Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Alzherimer’s Agitation/Aggression Treatment Revenue Market Share by Type (2020-2025)
Table 27. Global Alzherimer’s Agitation/Aggression Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Alzherimer’s Agitation/Aggression Treatment Revenue Market Share by Type (2026-2031)
Table 29. Global Alzherimer’s Agitation/Aggression Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Alzherimer’s Agitation/Aggression Treatment Revenue Market Share by Application (2020-2025)
Table 31. Global Alzherimer’s Agitation/Aggression Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Alzherimer’s Agitation/Aggression Treatment Revenue Market Share by Application (2026-2031)
Table 33. North America Alzherimer’s Agitation/Aggression Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Alzherimer’s Agitation/Aggression Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Alzherimer’s Agitation/Aggression Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Alzherimer’s Agitation/Aggression Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Alzherimer’s Agitation/Aggression Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Alzherimer’s Agitation/Aggression Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Alzherimer’s Agitation/Aggression Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Alzherimer’s Agitation/Aggression Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Alzherimer’s Agitation/Aggression Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Alzherimer’s Agitation/Aggression Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Alzherimer’s Agitation/Aggression Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Alzherimer’s Agitation/Aggression Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Alzherimer’s Agitation/Aggression Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Alzherimer’s Agitation/Aggression Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Alzherimer’s Agitation/Aggression Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 48. Eli Lilly and Company Company Details
Table 49. Eli Lilly and Company Business Overview
Table 50. Eli Lilly and Company Alzherimer’s Agitation/Aggression Treatment Product
Table 51. Eli Lilly and Company Revenue in Alzherimer’s Agitation/Aggression Treatment Business (2020-2025) & (US$ Million)
Table 52. Eli Lilly and Company Recent Development
Table 53. Pfizer Company Details
Table 54. Pfizer Business Overview
Table 55. Pfizer Alzherimer’s Agitation/Aggression Treatment Product
Table 56. Pfizer Revenue in Alzherimer’s Agitation/Aggression Treatment Business (2020-2025) & (US$ Million)
Table 57. Pfizer Recent Development
Table 58. Ono Pharmaceutical Company Details
Table 59. Ono Pharmaceutical Business Overview
Table 60. Ono Pharmaceutical Alzherimer’s Agitation/Aggression Treatment Product
Table 61. Ono Pharmaceutical Revenue in Alzherimer’s Agitation/Aggression Treatment Business (2020-2025) & (US$ Million)
Table 62. Ono Pharmaceutical Recent Development
Table 63. Otsuka Holdings Company Details
Table 64. Otsuka Holdings Business Overview
Table 65. Otsuka Holdings Alzherimer’s Agitation/Aggression Treatment Product
Table 66. Otsuka Holdings Revenue in Alzherimer’s Agitation/Aggression Treatment Business (2020-2025) & (US$ Million)
Table 67. Otsuka Holdings Recent Development
Table 68. GlaxoSmithKline Company Details
Table 69. GlaxoSmithKline Business Overview
Table 70. GlaxoSmithKline Alzherimer’s Agitation/Aggression Treatment Product
Table 71. GlaxoSmithKline Revenue in Alzherimer’s Agitation/Aggression Treatment Business (2020-2025) & (US$ Million)
Table 72. GlaxoSmithKline Recent Development
Table 73. Bristol-Myers Squibb Company Details
Table 74. Bristol-Myers Squibb Business Overview
Table 75. Bristol-Myers Squibb Alzherimer’s Agitation/Aggression Treatment Product
Table 76. Bristol-Myers Squibb Revenue in Alzherimer’s Agitation/Aggression Treatment Business (2020-2025) & (US$ Million)
Table 77. Bristol-Myers Squibb Recent Development
Table 78. Johnson & Johnson Company Details
Table 79. Johnson & Johnson Business Overview
Table 80. Johnson & Johnson Alzherimer’s Agitation/Aggression Treatment Product
Table 81. Johnson & Johnson Revenue in Alzherimer’s Agitation/Aggression Treatment Business (2020-2025) & (US$ Million)
Table 82. Johnson & Johnson Recent Development
Table 83. H. Lundbeck A/S Company Details
Table 84. H. Lundbeck A/S Business Overview
Table 85. H. Lundbeck A/S Alzherimer’s Agitation/Aggression Treatment Product
Table 86. H. Lundbeck A/S Revenue in Alzherimer’s Agitation/Aggression Treatment Business (2020-2025) & (US$ Million)
Table 87. H. Lundbeck A/S Recent Development
Table 88. AstraZeneca Company Details
Table 89. AstraZeneca Business Overview
Table 90. AstraZeneca Alzherimer’s Agitation/Aggression Treatment Product
Table 91. AstraZeneca Revenue in Alzherimer’s Agitation/Aggression Treatment Business (2020-2025) & (US$ Million)
Table 92. AstraZeneca Recent Development
Table 93. Eisai Company Details
Table 94. Eisai Business Overview
Table 95. Eisai Alzherimer’s Agitation/Aggression Treatment Product
Table 96. Eisai Revenue in Alzherimer’s Agitation/Aggression Treatment Business (2020-2025) & (US$ Million)
Table 97. Eisai Recent Development
Table 98. Biogen Company Details
Table 99. Biogen Business Overview
Table 100. Biogen Alzherimer’s Agitation/Aggression Treatment Product
Table 101. Biogen Revenue in Alzherimer’s Agitation/Aggression Treatment Business (2020-2025) & (US$ Million)
Table 102. Biogen Recent Development
Table 103. Novartis Company Details
Table 104. Novartis Business Overview
Table 105. Novartis Alzherimer’s Agitation/Aggression Treatment Product
Table 106. Novartis Revenue in Alzherimer’s Agitation/Aggression Treatment Business (2020-2025) & (US$ Million)
Table 107. Novartis Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
Table 111. Authors List of This Report
List of Figures
Figure 1. Alzherimer’s Agitation/Aggression Treatment Picture
Figure 2. Global Alzherimer’s Agitation/Aggression Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Alzherimer’s Agitation/Aggression Treatment Market Share by Type: 2024 VS 2031
Figure 4. Antipsychotics Features
Figure 5. Cholinesterase Inhibitors Features
Figure 6. Antidepressants Features
Figure 7. Others Features
Figure 8. Global Alzherimer’s Agitation/Aggression Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Alzherimer’s Agitation/Aggression Treatment Market Share by Application: 2024 VS 2031
Figure 10. Hospitals & Ambulatory Surgical Centers Case Studies
Figure 11. Psychiatric Care Facilities Case Studies
Figure 12. Others Case Studies
Figure 13. Alzherimer’s Agitation/Aggression Treatment Report Years Considered
Figure 14. Global Alzherimer’s Agitation/Aggression Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Alzherimer’s Agitation/Aggression Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Alzherimer’s Agitation/Aggression Treatment Market Share by Region: 2024 VS 2031
Figure 17. Global Alzherimer’s Agitation/Aggression Treatment Market Share by Players in 2024
Figure 18. Global Top Alzherimer’s Agitation/Aggression Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzherimer’s Agitation/Aggression Treatment as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Alzherimer’s Agitation/Aggression Treatment Revenue in 2024
Figure 20. North America Alzherimer’s Agitation/Aggression Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Alzherimer’s Agitation/Aggression Treatment Market Share by Country (2020-2031)
Figure 22. United States Alzherimer’s Agitation/Aggression Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Alzherimer’s Agitation/Aggression Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Alzherimer’s Agitation/Aggression Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Alzherimer’s Agitation/Aggression Treatment Market Share by Country (2020-2031)
Figure 26. Germany Alzherimer’s Agitation/Aggression Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Alzherimer’s Agitation/Aggression Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Alzherimer’s Agitation/Aggression Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Alzherimer’s Agitation/Aggression Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Alzherimer’s Agitation/Aggression Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Alzherimer’s Agitation/Aggression Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Alzherimer’s Agitation/Aggression Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Alzherimer’s Agitation/Aggression Treatment Market Share by Region (2020-2031)
Figure 34. China Alzherimer’s Agitation/Aggression Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Alzherimer’s Agitation/Aggression Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Alzherimer’s Agitation/Aggression Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Alzherimer’s Agitation/Aggression Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Alzherimer’s Agitation/Aggression Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Alzherimer’s Agitation/Aggression Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Alzherimer’s Agitation/Aggression Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Alzherimer’s Agitation/Aggression Treatment Market Share by Country (2020-2031)
Figure 42. Mexico Alzherimer’s Agitation/Aggression Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Alzherimer’s Agitation/Aggression Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Alzherimer’s Agitation/Aggression Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Alzherimer’s Agitation/Aggression Treatment Market Share by Country (2020-2031)
Figure 46. Turkey Alzherimer’s Agitation/Aggression Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Alzherimer’s Agitation/Aggression Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Alzherimer’s Agitation/Aggression Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Eli Lilly and Company Revenue Growth Rate in Alzherimer’s Agitation/Aggression Treatment Business (2020-2025)
Figure 50. Pfizer Revenue Growth Rate in Alzherimer’s Agitation/Aggression Treatment Business (2020-2025)
Figure 51. Ono Pharmaceutical Revenue Growth Rate in Alzherimer’s Agitation/Aggression Treatment Business (2020-2025)
Figure 52. Otsuka Holdings Revenue Growth Rate in Alzherimer’s Agitation/Aggression Treatment Business (2020-2025)
Figure 53. GlaxoSmithKline Revenue Growth Rate in Alzherimer’s Agitation/Aggression Treatment Business (2020-2025)
Figure 54. Bristol-Myers Squibb Revenue Growth Rate in Alzherimer’s Agitation/Aggression Treatment Business (2020-2025)
Figure 55. Johnson & Johnson Revenue Growth Rate in Alzherimer’s Agitation/Aggression Treatment Business (2020-2025)
Figure 56. H. Lundbeck A/S Revenue Growth Rate in Alzherimer’s Agitation/Aggression Treatment Business (2020-2025)
Figure 57. AstraZeneca Revenue Growth Rate in Alzherimer’s Agitation/Aggression Treatment Business (2020-2025)
Figure 58. Eisai Revenue Growth Rate in Alzherimer’s Agitation/Aggression Treatment Business (2020-2025)
Figure 59. Biogen Revenue Growth Rate in Alzherimer’s Agitation/Aggression Treatment Business (2020-2025)
Figure 60. Novartis Revenue Growth Rate in Alzherimer’s Agitation/Aggression Treatment Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
